Obesity-overweight and calcific aortic valve disease
Calcific aortic valve disease (CAVD) is a chronic disorder typified by ectopic mineralization and fibrosis of the aortic valve (AV), which may progress to the stage of aortic stenosis (AS). 1 Studies performed in the last decade have underlined that lipids and inflammation are important mediators of AV calcification and fibrosis. Intricate interactions between genes and the environment are believed to contribute to the development of CAVD. In this regard, Mendelian randomization studies have underscored that lipoprotein(a) [Lp(a)] and LDL were probably causally related to CAVD and AS. 2, 3 Among risk factors, age, type 2 diabetes, and hypertension have also been associated with CAVD. Obesity has been, so far, equivocally associated with CAVD. Small-scale and underpowered studies have provided conflicting results about the association between obesity and CAVD. Body mass index (BMI), a measure of total adiposity, has been shown to be either inversely or positively associated with the prevalence of CAVD. 4, 5 Hence, the association between obesity and CAVD has remained unsettled, until Larsson et al. in this issue of the journal provided convincing evidence that obesity is associated with an increased risk of AS. 6 In the ) and obesity (BMI > _30 kg/m 2 ) increased the risk of AS by 1.2-and 1.8-fold, respectively. In addition, overweight [hazard ratio (HR) 1.6] and obesity (HR 2.0) were also independently related to a hard endpoint such as surgical cases of AS requiring an aortic valve replacement (AVR). Though the study by Larsson et al. relied on the International Classification of Diseases codes to identify AS cases, the large number of incident cases and the strong association between overweight-obesity and surgically confirmed cases of AS provides compelling evidence that excessive adiposity is independently related to CAVD.
Ectopic fat: a link with the mineralization of the aortic valve?
Accumulated evidence suggests that body fat distribution has an important impact on risk prediction models. In this regard, studies have underlined that the amount of ectopic fat (adipose tissue accumulation in the abdomen, liver, skeletal muscle, and heart) strongly correlates with several markers of a dysmetabolic state and could have an incremental value in risk stratification models. 7 As such, elevated waist circumference (WC), a crude marker of visceral obesity, has been used in conjunction with different markers/risk factors in the so-called metabolic syndrome (MetS) to predict the cardiovascular risk. MetS is a predictor of AV calcification and is also independently associated with the progression rate of AS. 8 Though Larsson and colleagues did not measure variables such as triglyceride, HDL, or fasting glycaemia, they provided analyses after stratification of patients based on the BMI and WC. It is noteworthy that patients at higher risk were those who were overweight or obese and with an elevated WC (> _102 cm for men and > _88 cm for women). This analysis thus suggests that viscerally obese individuals are at higher risk of AS. The question of how obesity-at-risk is linked to AS and CAVD is still an unresolved issue. However, mounting evidence suggests that adipose tissue-specific mediators could play a significant role and may participate in the pathobiology of CAVD ( Figure 1 ). For instance, a high proportion of circulating small, dense LDL, a feature closely associated with visceral obesity and insulin resistance, has been linked with AV inflammation and remodelling. 9 Small, dense LDLs are prone to oxidation. In surgically explanted mineralized AVs, the valvular level of oxidized LDL (OxLDL) is linked with the amount of small, dense LDL in circulation. The plasma level of adiponectin, an adipocyte-specific cytokine, is decreased in viscerally obese patients and is associated with inflammation and remodelling of surgically 10 Increased inflammation in surgically explanted mineralized AVs has been linked with a faster progression rate of AS determined pre-operatively. More recently, our investigation has shown that autotaxin (ATX), a lysophospholipase that is secreted by valve interstitial cells (VICs) and adipocytes, promotes inflammation and mineralization of AV. 11 The circulating level of ATX, which is increased in individuals with obesity, is an independent predictor of AS. 12 Though further studies are needed to decipher the complex link between obesity and CAVD, these data suggest that adipose tissue-derived mediators could promote inflammation and mineralization of the AV.
Obesity and the burden of CAVD
The study by Larsson et al. has several important implications as it shows in a large prospective cohort of individuals an independent association between overweight-obesity and AS incidence. First, this study will foster further mechanistic work to uncover the molecular pathways whereby obesity and CAVD may be interconnected. In this regard, mouse models which recapitulate several features of obesity are available, and may help to identify the molecular processes. For instance, an energy-dense diet rich in lipid and sucrose promotes obesity, insulin resistance, and CAVD in LDLR -/-, apoB 100/100 IGFII transgenic mice. 13 Therefore, mouse models could be used to explore the molecular mechanisms that link adiposity to AV calcification and fibrosis. Secondly, this study adds CAVD to an already long list of diseases that are associated with obesity. Hence, the study by Larsson and colleagues should increase awareness as it has potential repercussions on public health issues. To this effect, assuming a causal relationship, Larsson et al. found in their series that 10% of AS cases were related to overweight and obesity. However, it is worth highlighting that the population-attributable risk of overweight-obesity on CAVD is probably higher as AS occurs only after several years to decades of progressive AV mineralization/fibrosis. In the last decade, the number of patients with AS has increased significantly in numerous countries. 1 It is possible that several factors such as the ageing of the population and newer modalities of diagnosis and treatment have contributed to this rise by increasing the referral of patients. However, it is likely that the 'obesogenic' environment, which has now spread around the globe, has contributed and will continue to increase the burden of CAVD. The late Professor Björntorp once coined the term 'Civilization Syndrome' to describe how the modern lifestyle had a major impact on chronic societal disorders. 14 Hence, the modern lifestyle combined with our modified environment is probably a significant contributor to 'Civilization Aortic Valve Disease', or CAVD if you will.
Lifestyle or genetics?
Larsson and colleagues rightly pointed out that Mendelian randomization studies, based on gene variants related to adiposity as an instrumental variable, should be performed and could shed light on the causal relationship between obesity and CAVD. Intensive research effort conducted after the completion of the Human Genome Project has provided important novel insights and a conceptual framework in identifying the genetic architecture for several diseases and conditions such as obesity. These findings have provided key mechanistic data for the research community and have increased the awareness among the public that genetics, and hence heritability, may contribute to increase the risk or susceptibility for different chronic diseases. However, a message that has been often conveyed in the media and the public is that some disorders are genetically determined and are thus not amenable to a significant risk reduction with a lifestyle modification programme. However, recent large-scale studies have shown substantial risk reduction in individuals with genotype-at-risk who had a healthy lifestyle and who controlled clinical risk factors such as LDL-cholesterol, blood pressure, and glucose. In the EPIC Norfolk study, Perrot et al. showed that participants with an elevated plasma level of Lp(a), a risk factor for CAVD which is largely genetically determined, and with an unhealthy lifestyle increased their cardiovascular risk by at least three-fold compared with subjects with an elevated Lp(a) level and an ideal cardiovascular health status. 15 Hence, these findings, including the work by Larsson et al., suggest that global and large-scale public health interventions are urgently needed at different levels to offer 'healthygenic' instead of 'obesogenic' environments to our modern population. The task is, however, not trivial as it involves multiscale interventions: for instance, the implementation of sustainable community-adapted health policies as well as urban plans that promote multimodal transportation including walking and cycling, instead of the highly prevalent car-focused model. 16 Along those lines, improving dietary quality will also have to become a priority if our goal is to reduce the burden of cardiovascular diseases substantially at the population level.
Conclusion
Hence, evidence indicates that overweight-obesity is a significant risk factor for CAVD. Among overweight-obese individuals; those with excess visceral adipose tissue as determined by the WC have the highest risk. This work by Larsson and colleagues will thus reinvigorate research to find the molecular processes that link dysfunctional adipose tissue to the biology of the AV. Moreover, this study highlighted that if causally related, overweight-obesity contributes to a significant number of AS cases. Although further research will also be needed to document if metrics associated with a healthy lifestyle could also be associated with the risk of CAVD, the time has come to invest in preventive measures. Targeting the widely adopted sedentary lifestyle and the consumption of ultraprocessed energy-dense foods could decrease the burden of cardiovascular diseases including CAVD.
